Jul 25, 2019
Matt Maurer speaks to The Globe and Mail regarding the ongoing situation at CannTrust
Shares of CannTrust Holdings Inc. dropped 22 per cent on Wednesday, a day after The Globe and Mail reported both CannTrust’s chairman and chief executive officer were informed about cannabis being grown in parts of a facility that had not been licensed seven months before Health Canada uncovered the regulatory breach.
Matt Maurer, the vice-chairman of Toronto-based Torkin Manes LLP’s Cannabis Law Group, said he’s received a large number of calls from U.S. financial institutions over the past several days inquiring about the situation at CannTrust.
“It seems like these calls are more like, ‘should we be selling and should we be shorting?’ versus, ‘where should we be looking to buy at the low end?’ ” Mr. Maurer said, referring to the practice of short-selling, where investors bet on share price declines.
This article was originally published on The Globe and Mail website. To read the complete article, visit The Globe and Mail.
Torkin Manes is honoured to be shortlisted by Chambers & Partners in the category of Regional Law Firm of the Year for the 2019 Chambers Canada Aw...
Aug 13, 2019
In the News
The fate of CannTrust Holdings Inc. is in Health Canada’s hands after the cannabis company formally responded to the regulator’s finding that it was g...
Jul 23, 2019
In the News
With fewer than 100 days to go before the launch of Canada’s hotly anticipated infused cannabis market, British Columbia’s government-run ...
Jul 15, 2019